Document:

Exhibit 10(h)

[Tenet Healthcare
Corporation Letterhead]

November 27, 2006

Personal & Confidential

Dr. Stephen Newman

13 Newcastle Lane

Laguna Niguel, CA  92677

Dear Dr. Newman:

I am pleased to confirm the details of your promotion
to become Tenet’s Chief Operating Officer with a start date of January 1,
2007.  You will report to Trevor Fetter,
President and CEO and you will office at Tenet’s Corporate Office in Dallas,
Texas.   Accordingly, you will continue
to be eligible for the following compensation and benefits package.

1.               Compensation and
Benefits

a.                           Base
Compensation:  Your base salary rate will be $700,000 per year,
payable bi-weekly.  Your salary will be
reviewed during the next applicable merit cycle.

b.                          Annual
Incentive Plan:  You remain eligible
for an annual incentive bonus according to the terms of the Tenet Annual
Incentive Plan (AIP).  Your Target Award
under the AIP is 90% of your annual salary.

c.                           Car
Allowance: You will receive an annual automobile allowance of $20,800 paid
bi-weekly.

d.                          Stock
Incentives:  Upon promotion, we would
recommend that the Compensation Committee of the Board of Directors approve a
one time equity grant of 50,400 RSUs. 
This is the difference between the 75th and 50th percentile of
market.  You would be eligible for the
ongoing equity grant provided by your role in February/March 2007.  Given the current Board guideline of 50th percentile of market, this would equate to a
grant of 315,000 option equivalents (equal to 126,000 RSUs).

e.                           Benefits:  You
will continue to be eligible to participate in Tenet’s benefit program which
provides health, life, dental, vision and disability insurance coverage.  In addition, we will provide you “in network”
pricing or the financial equivalent of “in network” pricing for services provided
at USC/Norris related to your spouse’s ongoing medical treatment.

f.                             Severance
Protection Agreement: You will continue to be eligible under the Executive
Severance Plan (ESP) under the same terms as provided for in your plan
agreement executed in July, 2006.

g.                          SERP:  You will remain a participant in the
Supplemental Executive Retirement Plan (SERP) which provides enhanced
retirement, disability and life insurance benefits.

Dr. Stephen Newman

11/21/06

Page 2 of 3

h.                          Relocation:  Tenet’s goal is to make your
relocation process as smooth as possible. 
Therefore, it is very important that you first
contact Shelley Giles, Tenet’s Relocation Director, at 469-893-6131, to
initiate your relocation benefits, prior to any relocation activities, e.g.
marketing and/or selling your home.

An itemized list of your
relocation benefits is attached. After review, please initial these pages and
return with your signed offer letter.

If you voluntarily terminate
your employment within twenty-four (24) months of your start date in the new
position, you will be required to reimburse Tenet on a pro-rated basis for such
relocation expenses paid to you or on your behalf (including any
gross-up).  The amount due is reduced
1/24th for each full month you remain employed by Tenet within the initial
24-month period (for example, 50% in the case of a voluntary termination at the
end of one year).

In addition, you agree that
upon acceptance of the COO role you and your family would move to the Dallas
area in an accelerated timeline.  Specifically, we would anticipate you to list
your current residence within 30 days of the effective date of your promotion,
and use best efforts to permanently relocate you and your family to the Dallas
area within 90 days of the effective date. 
Tenet would provide you a relocation package that would include a
provision for capital gains tax related to the sale of your home, if incurred.

2.               Employment
Status 

a.                           Compliance
with Tenet Policies, Rules and Regulations:  By signing this letter below, you agree to
abide by all Tenet Human Resources and other policies, procedures, rules and
regulations currently in effect or that may be adopted from time to time,
including the Tenet Performance Management policy and the Tenet Standards of
Conduct.  To the extent that any such
policies, rules or regulations, or any benefit plans in which you are a
participant, conflict with the terms of this letter, the actual terms of those
policies or plans shall control.

b.                          Ethics
Training: All Tenet employees are required to attend an initial ethics
class within their first 120 days of employment, as well as a refresher course
every fiscal year.  Please see your Human
Resources representative for more information on class times and dates, or
access the company Intranet site (eTenet) for additional information.

c.                           Standards
of Conduct:  As an employee of Tenet,
you agree to abide by Tenet’s Standards of Conduct, which reflect Tenet’s basic
values of high-quality, cost-effective health services; honesty,
trustworthiness, and reliability in all relationships; leadership in the
development of partnership arrangements with providers of health services; good
corporate citizenship of the communities where Tenet provides services; pursuit
of fiscal responsibility and growth; compliance with all applicable rules,
regulations, policies and procedures; and fair treatment of employees.

d.                          Conflict
Resolution:  As a condition of
employment, you agree to abide by Tenet’s Fair Treatment Process which includes
final and binding Arbitration as a resolution to any grievance that results out
of your employment or termination of employment.

Dr. Stephen Newman

11/21/06

Page 3 of 3

Finally, your employment with the company will be on
an at-will basis which means that either you or the company may terminate the
employment relationship with or without notice or with or without cause at any
time.  The term “cause” as used above
shall include, but not be limited to, dishonesty, fraud, willful misconduct,
self dealing or violation of the company’s Standards of Conduct, breach of
fiduciary duty (whether or not involving personal profit), failure, neglect or
refusal to perform your duties in any material respect, violation of law
(except traffic violations or similar minor infractions), violation of the company’s
Human Resources Operations or other Policies, or any material breach of this
agreement; provided, however, that a failure to achieve or meet business
objectives as defined by the company shall not be considered “cause” so long as
you have devoted your best and good faith efforts and full attention to the
achievement of those business objectives.

Dr. Newman, assuming these terms are agreeable, please
sign this letter indicating your acceptance and return to me.

Congratulations,
Dr. Newman, this is an important recognition in your career growth with Tenet
and I wish you success in your new position.

	
  Sincerely,

  	
   

  	
  ACCEPTED AND AGREED TO:

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  /s/ Cathy Fraser

  	
   

  	
  /s/ Stephen Newman

  	
   

  	
  11/27/06

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Cathy Fraser

  	
   

  	
  Dr. Stephen Newman

  	
   

  	
  Date

  
	
  SVP HRExhibit 10(u)

TENET HEALTHCARE
CORPORATION

SECOND AMENDED AND RESTATED

1994 DIRECTORS STOCK OPTION PLAN

(as amended effective August 15, 2002)

1.             PURPOSE OF PLAN.

The purpose of the Second Amended and Restated 1994
Directors Stock Option Plan of Tenet Healthcare Corporation is to promote the
interests of the Company and its shareholders by strengthening the Company’s
ability to attract, motivate and retain Directors of training, experience and
ability, and to encourage the highest level of Directors’ performance by
providing Directors with a proprietary interest in the Company’s financial
success and growth.

2.             DEFINITIONS.

(a)           “Board”
means the Board of Directors of the Company.

(b)           “Committee”
means the Compensation and Stock Option Committee of the Board as shall be
appointed by the Board from time to time.

(c)           “Common
Stock” means the $.075 par value Common Stock of the Company.

(d)           “Company”
means Tenet Healthcare Corporation, a Nevada corporation, formerly known as
National Medical Enterprises, Inc.

(e)           “Director”
means a member of the Board who is not an Employee.

(f)            “Employee”
means any full-time employee of the Company, or of any of its subsidiaries.

(g)           “Fair
Market Value” means the closing price of a share of Common Stock on the New
York Stock Exchange on the date as of which fair market value is to be
determined or the actual sale price of the shares acquired upon exercise if the
shares are sold in a same day sale, or if no sales were made on such date, the
closing price of such shares on the New York Stock Exchange on the next
preceding date on which there were such sales.

(h)           “Grant
Date” means the date on which an Option is granted to a Director.

(i)            “Initial
election” means election to the Board by the Board or by the shareholders of
the Company, whichever first occurs.

(j)            “Option”
means a non-qualified stock option.

(k)           “Plan”
means the Company’s Second Amended and Restated 1994 Directors Stock Option
Plan, as amended from time to time.

3.             SHARES OF COMMON STOCK SUBJECT TO THIS PLAN.

Subject to the provisions of Section 7, the aggregate
number of shares of Common Stock that may be issued or transferred pursuant to
exercise of Options under this Plan is 1,200,000 shares of Common Stock. Such
shares may be either authorized but unissued shares of Common Stock or treasury
shares.

4.             ADMINISTRATION OF THIS PLAN.

(a)           This
Plan shall be administered by the Committee, which shall have     the power to interpret this Plan and,
subject to its provisions, to prescribe, amend and rescind rules and to make
all other determinations necessary for this Plan’s administration.

(b)           All
action taken by the Committee in the administration and interpretation of this
Plan shall be final and binding upon all parties. No member of the Committee
will be liable for any action or determination made in good faith by the
Committee with respect to this Plan or any Option.

5.             ELIGIBILITY.

(a)           Only
Directors shall be eligible to participate in this Plan. Each Director who is
serving in such capacity on the Grant Date automatically shall be granted, on
the last Thursday of October of each year, an Option to acquire the greater of
(x) 10,000 shares of Common Stock and (y) the number of shares of Common Stock
determined by dividing (i) the product of four times the then-existing annual
retainer fee, by (ii) the Fair Market Value on the Grant Date.

(b)           Upon
Initial Election to the Board, each Director automatically shall be granted, on
the last Thursday of the month of such Director’s election to the Board, an
Option to acquire two times the greater of (x) 10,000 shares of Common Stock
and (y) the number of shares of Common Stock determined by dividing (i) the
product of four times the then-existing annual retainer fee, by (ii) the Fair
Market Value on the Grant Date.

(c)           Each
Option will be evidenced by a written instrument including terms and conditions
consistent with this Plan, as the Committee may determine.

6.             TERMS AND CONDITIONS OF STOCK OPTIONS.

(a)           The
purchase price of Common Stock under each Option will be the Fair Market Value
on the Grant Date. Notwithstanding any other provision to the contrary
contained in this Plan, including without limitation, Sections 6(c)(i), (ii)
and (iii), each Option will expire not later than ten years from the Grant
Date.

(b)           The
Committee shall have the discretion to set the vesting terms for all Options
granted under this Plan, including the discretion to grant Options that vest
immediately upon grant. Upon vesting, an Option may be exercised with respect
to all shares of Common Stock covered thereby during its term provided
hereunder.

(c)           Subject
to the provisions of Section 6(a), each Option will expire at the time the
Director ceases to be a Director, except as follows:

 2
 

(i)            If the service of the Director is
terminated by the Company other than for cause, for which the Company will be
the sole judge, or if the Director is nominated but is not reelected by the
shareholders of the Company, then the Option will expire one year after the
date of termination;

(ii)           If the Director retires at or after
age 65, or retires with the consent of the Committee, the Option will expire
five years after the date of retirement.

(iii)          If the Director dies or becomes
permanently and totally disabled while serving in such capacity, the Option
will expire five years after the date of death or permanent and total
disability. If the Director dies or becomes permanently and totally disabled
within the one-year period referred to in subparagraph (i) above, the Option
will expire one year after the date of death or permanent and total disability.
If the Director dies or becomes permanently and totally disabled within the
five-year period referred to in subparagraph (ii) above, the Option will expire
upon the later of five years after retirement or one year after the date of
death or permanent and totally disability.

(d)           Effective
August 15, 2002, the exercise price of an Option and any federal and state
withholding obligation resulting from the exercise of such Option, will be
payable in full (i) upon exercise, in cash, (ii) by the Director
irrevocably authorizing a broker approved in writing by the Company to sell
shares of Common Stock acquired through exercise of the Option and remitting to
the Company a sufficient portion of the sale proceeds to pay the entire exercise
price and any federal and state withholding resulting from such exercise (a “cashless
exercise”); provided that, notwithstanding anything in this Plan to the
contrary, (A) the Company shall issue such shares of Common Stock only at or
after the time the Company receives full payment for such shares, (B) the
exercise price for such shares of Common Stock will be due and payable to the
Company no later than one business day following the date on which the proceeds
from the sale of the underlying shares of Common Stock are received by the
authorized broker, and (C) in no event will the Company directly or
indirectly extend or maintain credit, arrange for the extension of credit or
renew any extension of credit, in the form of a personal loan or otherwise, in
connection with a cashless exercise, (iii) in the discretion of the Committee,
upon exercise, by the assignment and delivery to the Company of shares of
Common Stock owned by the Director, or (iv) by a combination of any of the
above. Any shares assigned and delivered to the Company in payment or partial
payment of the exercise price will be valued at the Fair Market Value on the
exercise date and shall be accompanied by an assignment separate from
certificate and any other document(s) reasonably requested by the Company.

7.             ADJUSTMENT PROVISIONS.

(a)           Subject
to Section 7(b), if the outstanding shares of Common Stock of the Company are
increased, decreased, or exchanged for a different number or kind of shares or
other securities, or if additional shares or new or different shares or other
securities are distributed with respect to such shares of Common Stock or other
securities, through merger, consolidation, spin-off, sale of all or
substantially all the assets of the Company, reorganization, recapitalization,
reclassification, stock dividend, stock split, reverse stock split or other
distribution with respect to such shares of Common Stock, or other securities,
an appropriate and proportionate adjustment may be made in (i) the maximum
number and kind of shares provided in Section 3 and Section 5 and (ii) the
number and kind of shares or other securities subject to, and the purchase
price in, then-outstanding Options.

 3
 

(b)           Notwithstanding
the provisions of Section 7(a), upon dissolution, or liquidation of the Company
or upon a reorganization, merger or consolidation of the Company with one or
more corporations as a result of which the Company is not the surviving
corporation, or upon the sale of all or substantially all the assets of the
Company, all Options then outstanding under this Plan will be fully vested and
the restrictions upon exercise in Section 6(b) will immediately cease, unless
provisions are made in connection with such transaction for the continuance of
this Plan or the assumption or the substitution for such Options of new options
covering the stock of a successor corporation, or a parent or subsidiary
thereof, with appropriate adjustments as to the number and kind of shares and
prices.

(c)           Adjustments
under Section 7(a) and 7(b) will be made by the Committee, whose determination
as to what adjustments will be made and the extent thereof will be final,
binding, and conclusive. No fractional interest will be issued under this Plan
on account of any such adjustments.

(d)           Upon
the occurrence of a “Change of Control” of the Company, all Options then
outstanding under this Plan will be fully vested and the restrictions upon
exercise in Section 6(b) will immediately cease. For purposes of this Section
7(d) the following definitions shall apply:

(i)            A “Change in Control” of the Company
shall have occurred when a Person, alone or together with its Affiliates and
Associates, becomes the beneficial owner of 20% or more of the general voting
power of the Company.

(ii)           “Affiliate” and “Associate” shall
have the respective meanings ascribed to such terms in Rule 12b-2 of the
General Rules and Regulations under the Securities and Exchange Act of 1934, as
amended (the “Exchange Act”)

(iii)          “Person” shall mean an individual,
firm, corporation or other entity or any successor to such entity, but “Person”
shall not include the Company, any subsidiary of the Company, any employee
benefit plan or employee stock plan of the Company, or any Person organized,
appointed, established or holding Voting Stock by, for or pursuant to the terms
of such a plan or any Person who acquires 20% or more of the general voting
power of the Company in a transaction or series of transactions approved prior
to such transaction or series of transactions by the Board.

(iv)          “Voting Stock” shall mean shares of
the Company’s capital stock having general voting power, with “voting power”
meaning the power under ordinary circumstances (and not merely upon the
happening of a contingency) to vote in the election of directors.

8.             GENERAL PROVISIONS.

(a)           Nothing
in this Plan or in any instrument executed pursuant to this Plan will confer
upon any Director any right to continue as a Director or affect the right of
the Company to terminate the services of any Director in accordance with the
bylaws of the Company.

(b)           No
shares of Common Stock will be issued or transferred pursuant to an Option
unless and until all then-applicable requirements imposed by federal and state
securities and other laws, rules and regulations and by any regulatory agencies
having jurisdiction, and by any stock exchanges upon which the Common Stock may
be listed, have been fully met. As a 

 4
 

condition precedent to the issuance of shares pursuant to the exercise
of an Option, the Company may require the Director to take any reasonable action
to meet such requirements.

(c)           No
Director and no beneficiary or other person claiming under or through such
Director will have any right, title or interest in or to any shares of Common
Stock allocated or reserved under this Plan or subject to any Option except as
to such shares of Common Stock, if any, that have been issued or transferred to
such Director.

(d)           No
Option and no right under this Plan, contingent or otherwise, will be
assignable or subject to any encumbrance, pledge or charge of any nature except
(i) with the written consent of the Committee, (ii) an assignment in favor of
the Company, and (iii) under such rules and regulations as the Committee may
establish pursuant to the terms of this Plan.

(e)           No
Option and no right under this Plan, contingent or otherwise, will be
transferable by a Director other than by will or the laws of descent and
distribution or pursuant to a qualified domestic relations order as defined by
the Internal Revenue Code of 1986, as amended (the “Code”) or Title I of the
Employee Retirement Income Security Act (“ERISA”), or the rules thereunder. The
designation of a beneficiary by a Director does not constitute a transfer.

9.             AMENDMENT AND TERMINATION.

(a)           The
Board will have the power, in its discretion, to amend, suspend or terminate
this Plan at any time, subject to approval of the shareholders of the Company
if and to the extent necessary for the continued applicability of Rule 16b-3
under the Exchange Act.

(b)           No
amendment, suspension or termination of this Plan will, without the consent of
the holder, alter, terminate, impair or adversely affect any right or
obligation under any Option previously granted under this Plan.

(c)           Notwithstanding
the provisions of Section 9(a), the Board may not amend the provisions of
Section 5 or the definition of “Director” in Section 2 more than once every six
months, other than to comport with changes in the Code, ERISA or the rules
thereunder.

10.          EFFECTIVE DATE OF PLAN AND DURATION OF
PLAN.

This amended Plan is effective as of July 26, 2000,
except as specified otherwise herein. Unless this Plan is previously
terminated, this Plan will terminate on July 26, 2010 except with respect to
Options then outstanding.

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}]]